🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

[1/2] Congratulations to Dr. Maha Othman who received a Minister’s Award of Excellence in the #EverydayHeroes category.

Both physical and mental QoL are significantly affected by VTE complications, important patient reported outcomes from the Garfield study! Nicola Potere Marc Carrier #ISTH2025

If you’re attending #ISTH25, be sure to learn about “Predictors of Anticoagulant-Related Bleeding in Patients with Cancer: A Meta-Analysis” in room 202 A & B at 245pm today in the Cancer and Thrombosis I session presented by Faizan Khan, PhD #thrombosis #research

🩸 Do you wonder if abiraterone has drug–drug interactions with DOACs in patients with cancer? A population-level study in men with prostate cancer found no increased bleeding risk with concurrent use of abiraterone and DOACs vs. other anticoagulants. Tzu-Fei Wang 📍 #ISTH2025

🩸 Meta-analysis presented at #ISTH2025 and simultaneously published in EHJ Editor-in-Chief found that several risk factors (e.g., previous history of VTE or bleeding, advanced cancer, and specific cancer sites) are associated with recurrent VTE and bleeding in patients with CAT.

How to manage cancer patients with small #VTE (distal DVT and SSPE)? Poster presentation by Roger Kou at #ISTH2025 showed that AC is associated with a lower risk of recurrent #VTE in distal DVT!! Marc Carrier Aurélien Delluc Dr.Le Gal 👇

🚨📣 A long-awaited study from my #BantingCanada fellowship examining predictors of recurrent #VTE and anticoagulant-related🩸 #bleeding in patients with cancer was published in #EHJ today to coincide with my live presentation at #ISTH2025‼️ academic.oup.com/eurheartj/adva…

🫁 A COPD-specific diagnostic strategy for PE was retrospectively validated and found to be safe using a 3-item score + D-dimer with 2 cut-offs, 50% of patients avoided imaging. 🔍 Signs of DVT, non-purulent AECOPD, and PE as most likely dx #ISTH2025 #VTE #COPD

🩸 Clots tend to come back at the same site as the index VTE! Among 708 patients with prior VTE, recurrences often occurred at the same site as the original event, especially ipsilateral DVTs. Familiar symptoms? Trust your clinical instincts. #ISTH2025 #VTE #DVT

At #ISTH2025 ? Don’t miss Prof. Le Gal present on the network endorsed Adjust-#DVT study at 10:30 am ET in room 146 A-C. An incredible multi-national research achievement! #thrombosis #research

📢 Practice-changing data from the Adjust-DVT study! ✅ Age-adjusted D-dimer safely rules out DVT in low/non-high pretest probability patients 📉 Reduces unnecessary ultrasounds 🔍 +17% yield in patients ≥75 years #ISTH2025 #DVT #Thrombosis #LessIsMore

Come say hello to David Airdrie, our Executive Director at Thrombosis Canada, at Booth 623! 👋 Learn more about our clinical guides, patient resources, and upcoming education initiatives. 📍#ISTH2025 – We’re here to connect! Thrombosis Canada

🧠 #ISTH2025 SCC survey on stroke in cancer patients: 1️⃣ Physicians choose reperfusion strategies differently for patients with vs. without cancer 2️⃣ Antiplatelets remain the most used for secondary prevention regardless of cancer 3️⃣ Major equipoise on workup post-stroke in

🩸 Important findings from Dr Yan Xu at #ISTH2025: Black individuals on extended anticoagulation for secondary VTE prevention had higher rates of major bleeding, including ICH, than White individuals. 🔎 No difference in CRNMB. 📢 Calls for action to address racial

🩸 WaVE Study Alert! In patients with acute CAT & weight >90kg, weight-based dalteparin (200 IU/kg) appears safe & effective. 🔹 Anti-Xa levels aligned with non-obese patients 🔹 Higher levels seen in those with bleeding Important data to guide dosing in CAT & obesity.

Thanks for the shout out Patricia. As the incoming chair for this SSC, now working with colleagues to structure our projects agenda and priorities for the next few years we welcome ideas, new project leads and collaborations.

Have you downloaded the latest episode of CLOT Conversations yet? Learn what the contestants of the INVENT-VTE "Dragon's Den" pitched to get support for their studies, like Dr Francis Couturaud (@fcouturaud) with his ETHER Study. Access it here: buzzsprout.com/1946680/episod… or on

🧠 Diagnosing recurrent VTE is challenging. PREDICTORS study (n=723) showed that existing clinical decision rules (CDRs) identify patients at higher risk and RO recurrence without imaging in ~15% 📊 In low/moderate-risk PE with negative D-dimer: 🟢 0/82 recurrent VTE (0%; 95% CI